A -year-old man with decompensated cirrhosis due to alcohol use disorder is evaluated on hospital day for ongoing management of spontaneous bacterial peritonitis. He initially presented with a temperature of (), diffuse abdominal pain, and confusion. Diagnostic paracentesis on admission showed an ascitic fluid absolute neutrophil count of . Because of a history of extended-spectrum beta-lactamase (ESBL)-producing *Escherichia coli* bacteriuria months ago, he was empirically started on intravenous meropenem. Intravenous albumin ( g/kg) was also administered on admission based on the following laboratory results:
Admission (Day 1):
Blood urea nitrogen: mg/dL
Serum creatinine: mg/dL
Total bilirubin: mg/dL
Today (Day 3), the patient is feeling much better. His temperature is (), and his mental status has returned to baseline. Ascitic fluid cultures from admission have grown *Klebsiella pneumoniae*. Antimicrobial susceptibility testing is as follows:
Ampicillin: Resistant
Ceftriaxone: Susceptible
Ciprofloxacin: Susceptible
Meropenem: Susceptible
Piperacillin-tazobactam: Susceptible
Current laboratory results:
Blood urea nitrogen: mg/dL
Serum creatinine: mg/dL
Total bilirubin: mg/dL
Which of the following is the most appropriate next step in the management of this patient?
- AContinue intravenous meropenem and administer intravenous albumin
- BContinue intravenous meropenem and withhold intravenous albumin
- Switch to intravenous ceftriaxone and administer intravenous albuminCevap
- DSwitch to intravenous ceftriaxone and withhold intravenous albumin
- ESwitch to oral ciprofloxacin and withhold intravenous albumin